ArticleChemical biology & drug design2025

Repurposing of FDA-Approved Drugs to Disrupt Iron Uptake in Mycobacterium abscessus: Targeting Salicylate Synthase as a Novel Approach.

Giovanni Stelitano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.